Clinical characteristics and prognosis of prostate cancer after prostatectomy for benign prostatic hyperplasia in 13 cases

Chao Lu,Bao Hua,Yuanshen Mao,Xin Gu,Wenfeng Li,Yufei Gu,Weixin Pan,Fukun Tong,Shiqing Zhang,Zhikang Cai,Zhong Wang
DOI: https://doi.org/10.3969/j.issn.1008-0848.2017.02.006
2017-01-01
Abstract:Objective To analyze the clinical features and prognosis of prostate cancer (PCa) after prostatectomy for benign prostatic hyperplasia (BPH), and improve the understanding of this disease. Methods Clinical data of 13 patients with Pca, who confirmed by pathological examination from March 2006 to September 2016, after prostatectomy for BPH were analyzed retrospectively. The mean age was 81.3 years old(range from 74 to 85 years old). The mean intervals between prostatectomy for BPH and the diagnosis of prostate cancer was 4.6 years (range from 4 months to 21 years). Clinical data of 13 cases underwent operation for BPH: The serum prostate specific antigen(PSA) was determined in 10 patients with BPH, the values of PSA were normal in 2 cases, were in gray area (4~10ng/mL) in 7 cases and elevated in one case. The surgical methods of BPH were suprapubic prostatectomy in 5 cases and transurethral resection of the prostate (TURP) in 8 cases. The main symptoms of those who needed retreatment were dysuria in 8 cases, hematuria in 2 cases, dysuria with hematuria in 2 cases, no symptom with abnormal PSA in one case. Digital rectal examinations(DRE) were abnormal in 11 cases. B ultrasound examinations were abnormal in 7 cases. PSA was elevated in all cases. Histopathology diagnosis were adenocarcinoma of prostate and established by TURP in one case and ultrasound guided transrectal core biopsies of the prostate in 12 cases. All cases received hormonal therapy, among them 8 cases were bilateral orchiectomy combined with antiandrogen drugflutamide, 3 cases were drug castration combined with antiandrogen drugflutamide, one case was bilateral orchiectomyand, one case was antiandrogen drugflutamide only, 3 cases who were bilateral combined with antiandrogen received additional treatment of TURP. Results During the 4 months to 10 years follow-up, 12 cases completed following-up,one case was lost after 3 years follow- up. One-year, three-year and five-year survival rate were 100%(13/13), 76%(10/13) and 50%(6/12). Of the six death cases, 3 were related with the cancer while other 3 were not related with the cancer. Conclusion Onset sites of BPH and Pca in prostate are different. Pca may still occur after resection of benign prostatic hyperplasia. The patients after prostatectomy should be followed up at regular intervals for early diagnosis and treatment. The aged prostate cancer patients develop slowly.
What problem does this paper attempt to address?